Your institution may have access to this item. Find your institution then sign in to continue.
Title
Melanoma Death Rates Are Falling Fast, Thanks to Immunotherapy.
Abstract
The article reports that two-year survival rates for patients with advanced melanoma has increased immediately after the introduction of ipilimumab in 2011, according to a study published in the journal "Cancer."